Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

NARecruitingINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

July 30, 2025

Study Completion Date

October 30, 2025

Conditions

NarcolepsyIdiopathic HypersomniaCataplexy

Interventions

DIAGNOSTIC_TEST

Quantitative mass spectrometry assay

ORX-A determination by quantitative mass spectrometry

Trial Locations (1)

RECRUITING

University Hospital of Montpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER